Skip to main content

Table 1 Biochemical and genetic characteristics of 49 patients with primary carnitine deficiency (PCD)

From: Correction to: Biochemical and genetic characteristics of patients with primary carnitine deficiency identified through newborn screening

Patient no.

Gender

C0

C0-F1

Genotype

References

1

Male

4.61

6.29

c.51C>G (p.F17L)

c.1195C>T (p.R399W)

This study

2

Female

3.28

3.17

c.51C>G (p.F17L)

c.51C>G (p.F17L)

This study

3

Female

2.37

1.05

c.338G>A (p.C113Y)

c.760C>T (p.R254*)

This study

4

Male

7.65

5.04

c.51C>G (p.F17L)

c.1400C>G (p.S467C)

This study

5

Male

3.75

3.19

c.760C>T (p.R254*)

c.1400C>G (p.S467C)

This study

6

Male

2.72

2.86

c.844C>T (p.R282*)

c.1400C>G (p.S467C)

This study

7

Female

2.54

2.29

c.695C>T (p.T232M)

c.760C>T (p.R254*)

This study

8

Male

5.29

6.58

c.51C>G (p.F17L)

c.1195C>T (p.R399W)

This study

9

Female

5.02

5.53

c.428C>T (p.P143L)

c.428C>T (p.P143L)

This study

10

Female

1.63

1.67

c.760C>T (p.R254*)

c.760C>T (p.R254*)

This study

11

Male

2.31

2.76

c.51C>G (p.F17L)

c.1161T>G (p.Y387*)

This study

12

Female

3.49

3.52

c.51C>G (p.F17L)

c.760C>T (p.R254*)

Lin et al. 2020 [10]

13

Male

1.96

1.73

c.51C>G (p.F17L)

c.760C>T (p.R254*)

Lin et al. 2021 [21]

14

Female

2.40

1.44

c.760C>T (p.R254*)

c.760C>T (p.R254*)

Lin et al. 2021 [21]

15

Male

5.78

10.67

c.760C>T (p.R254*)

c.797C>T (p.P266L)

Lin et al. 2021 [21]

16

Male

5.95

8.64

c.695C>T (p.T232M)

c.1160A>G (p.Y387C)

Lin et al. 2021 [21]

17

Female

7.27

6.66

c.760C>T (p.R254*)

c.797C>T (p.P266L)

Lin et al. 2021 [21]

18

Female

5.58

5.59

c.760C>T (p.R254*)

c.1400C>G (p.S467C)

Lin et al. 2021 [21]

19

Female

5.34

6.02

c.797C>T (p.P266L)

c.394-1G>A

Lin et al. 2021 [21]

20

Female

1.78

1.90

c.695C>T (p.T232M)

c.1139C>T (p.A380V)

Lin et al. 2021 [21]

21

Male

4.34

4.45

c.51C>G (p.F17L)

c.51C>G (p.F17L)

Lin et al. 2021 [21]

22

Female

4.75

4.16

c.760C>T (p.R254*)

c.845G>A (p.R282Q)

Lin et al. 2021 [21]

23

Female

3.45

5.24

c.760C>T (p.R254*)

c.1400C>G (p.S467C)

Lin et al. 2021 [21]

24

Female

6.82

5.02

c.760C>T (p.R254*)

c.1400C>G (p.S467C)

Lin et al. 2021 [21]

25

Male

2.19

2.12

c.822G>A (p.W274*)

c.782_799del ((p.V261_P266del)

Lin et al. 2021 [21]

26

Male

2.73

9.84

c.51C>G (p.F17L)

c.1144_1162del (p.V382Cfs*45)

Lin et al. 2021 [21]

27

Male

3.00

10.81

c.51C>G (p.F17L)

c.1400C>G (p.S467C)

Lin et al. 2021 [21]

28

Male

6.46

5.10

c.695C>T (p.T232M)

c.1400C>G (p.S467C)

Lin et al. 2021 [21]

29

Male

3.02

1.77

c.760C>T (p.R254*)

c.760C>T (p.R254*)

Lin et al. 2021 [21]

30

Female

6.77

10.05

c.1400C>G (p.S467C)

c.1400C>G (p.S467C)

Lin et al. 2021 [21]

31

Female

2.36

1.75

c.760C>T (p.R254*)

c.760C>T (p.R254*)

Lin et al. 2021 [21]

32

Female

3.12

2.88

c.760C>T (p.R254*)

c.51C>G (p.F17L)

Lin et al. 2021 [21]

33

Male

3.64

3.80

c.695C>T (p.T232M)

c.1139C>T (p.A380V)

Lin et al. 2021 [21]

34

Female

3.56

4.31

c.760C>T (p.R254*)

c.1139C>T (p.A380V)

Lin et al. 2021 [21]

35

Female

6.27

3.43

c.695C>T (p.T232M)

c.1139C>T (p.A380V)

Lin et al. 2021 [21]

36

Female

2.70

3.46

c.760C>T (p.R254*)

c.51C>G (p.F17L)

Lin et al. 2021 [21]

37

Male

7.35

14.27

c.338G>A (p.C113Y)

c.338G>A (p.C113Y)

Lin et al. 2021 [21]

38

Male

8.25

2.51

c.51C>G (p.F17L)

c.338G>A (p.C113Y)

Lin et al. 2019 [26]

39

Male

2.45

1.14

c.760C>T (p.R254*)

c.760C>T (p.R254*)

Lin et al. 2019 [26]

40

Male

2.8

1.74

c.760C>T (p.R254*)

c.1161T>G (p.Y387*)

Lin et al. 2019 [26]

41

Female

6.83

4.59

c.760C>T (p.R254*)

c.1400C>G (p.S467C)

Lin et al. 2019 [26]

42

Female

6.22

11.14

c.760C>T (p.R254*)

c.1400C>G (p.S467C)

Lin et al. 2019 [26]

43

Female

6.16

4.02

c.695C>T (p.T232M)

c.1400C>G (p.S467C)

Lin et al. 2019 [26]

44

Male

6.77

4.5

c.760C>T (p.R254*)

c.1400C>G (p.S467C)

Lin et al. 2019 [26]

45

Female

4.91

6.66

c.250T>A (p.Y84N)

c.1400C>G (p.S467C)

Lin et al. 2019 [26]

46

Male

3.24

4.05

c.51C>G (p.F17L)

c.1196G>A (p.R399Q)

Lin et al. 2019 [26]

47

Male

4.96

5

c.51C>G (p.F17L)

c.1195C>T (p.R399W)

Lin et al. 2019 [26]

48

Female

3.15

4.09

c.760C>T (p.R254*)

c.1400C>G (p.S467C)

Lin et al. 2019 [26]

49

Female

4.12

1.29

c.760C>T (p.R254*)

c.760C>T (p.R254*)

Lin et al. 2019 [26]

  1. The C0 levels within the cut-of value are given in bold
  2. C0: free carnitine detected at newborn screening, C0-F1: C0 retested at recall stage, cutoff value: 8.5–50 μmol/L